Suppr超能文献

病原体驱动的胃肠道癌症:治疗范式转变的时机?

Pathogen-driven gastrointestinal cancers: Time for a change in treatment paradigm?

机构信息

Nazarbayev University, 53 Kabanbay Batyr Avenue, Astana 010000, Kazakhstan.

出版信息

Infect Agent Cancer. 2012 Aug 8;7(1):18. doi: 10.1186/1750-9378-7-18.

Abstract

The regulation of cancerous tumor development is converged upon by multiple pathways and factors. Besides environmental factors, gastrointestinal (GI) tract cancer can be caused by chronic inflammation, which is generally induced by bacteria, viruses, and parasites. The role of these inducers in cancer development, cell differentiation and transformation, cell cycle deregulation, and in the expression of tumor-associated genes cannot be ignored. Although Helicobacter pylori activates many oncogenic pathways, particularly those in gastric and colorectal cancers, the role of viruses in tumor development is also significant. Viruses possess significant oncogenic potential to interfere with normal cell cycle control and genome stability, stimulating the growth of deregulated cells. An increasing amount of recent data also implies the association of GI cancers with bacterial colonization and viruses. This review focuses on host-cell interactions that facilitate primary mechanisms of tumorigenesis and provides new insights into novel GI cancer treatments.

摘要

癌症肿瘤的发展受到多种途径和因素的调节。除了环境因素外,胃肠道(GI)癌症还可能由慢性炎症引起,这种炎症通常是由细菌、病毒和寄生虫引起的。这些诱导物在癌症发展、细胞分化和转化、细胞周期失控以及肿瘤相关基因表达中的作用不容忽视。虽然幽门螺杆菌激活了许多致癌途径,特别是在胃癌和结直肠癌中,但病毒在肿瘤发展中的作用也很重要。病毒具有显著的致癌潜力,可以干扰正常的细胞周期控制和基因组稳定性,刺激不受调节的细胞生长。越来越多的最新数据也暗示了 GI 癌症与细菌定植和病毒之间的关联。本综述重点关注促进肿瘤发生的主要机制的宿主细胞相互作用,并为新型 GI 癌症治疗提供新的见解。

相似文献

1
Pathogen-driven gastrointestinal cancers: Time for a change in treatment paradigm?
Infect Agent Cancer. 2012 Aug 8;7(1):18. doi: 10.1186/1750-9378-7-18.
2
Gut Microbiome and Gastrointestinal Cancer: Les liaisons Dangereuses.
J Clin Gastroenterol. 2016 Nov/Dec;50 Suppl 2, Proceedings from the 8th Probiotics, Prebiotics & New Foods for Microbiota and Human Health meeting held in Rome, Italy on September 13-15, 2015:S191-S196. doi: 10.1097/MCG.0000000000000714.
4
The role of microRNAs in Helicobacter pylori pathogenesis and gastric carcinogenesis.
Front Cell Infect Microbiol. 2012 Jan 3;1:21. doi: 10.3389/fcimb.2011.00021. eCollection 2011.
5
The NF-κB Signaling Pathway, the Microbiota, and Gastrointestinal Tumorigenesis: Recent Advances.
Front Immunol. 2020 Jun 30;11:1387. doi: 10.3389/fimmu.2020.01387. eCollection 2020.
6
The Role of Gut Microbiota in Gastrointestinal Tract Cancers.
Arch Immunol Ther Exp (Warsz). 2022 Feb 3;70(1):7. doi: 10.1007/s00005-021-00641-6.
7
Gastrointestinal microbiome and : Eradicate, leave it as it is, or take a personalized benefit-risk approach?
World J Gastroenterol. 2022 Feb 21;28(7):766-774. doi: 10.3748/wjg.v28.i7.766.
8
Tumor Suppressor microRNAs in Gastrointestinal Cancers: A Mini-Review.
Recent Adv Inflamm Allergy Drug Discov. 2022;16(1):5-15. doi: 10.2174/2772270816666220606112727.
9
Periodontitis, Helicobacter pylori infection, and gastrointestinal tract cancer mortality.
J Clin Periodontol. 2022 Mar;49(3):210-220. doi: 10.1111/jcpe.13590. Epub 2022 Jan 2.
10
Role of Microbial Infection-Induced Inflammation in the Development of Gastrointestinal Cancers.
Medicines (Basel). 2021 Aug 17;8(8):45. doi: 10.3390/medicines8080045.

引用本文的文献

1
Anticancer properties and metabolomic profiling of Shorea roxburghii extracts toward gastrointestinal cancer cell lines.
BMC Complement Med Ther. 2024 Apr 30;24(1):178. doi: 10.1186/s12906-024-04479-1.
2
Dyslipidemia and non-small cell lung cancer risk in Chinese population: a case-control study.
Lipids Health Dis. 2018 Dec 6;17(1):278. doi: 10.1186/s12944-018-0925-z.
3
Case-control study of metabolic syndrome and ovarian cancer in Chinese population.
Nutr Metab (Lond). 2017 Feb 28;14:21. doi: 10.1186/s12986-017-0176-4. eCollection 2017.
4
Prolonged inflammatory microenvironment is crucial for pro-neoplastic growth and genome instability: a detailed review.
Inflamm Res. 2017 Feb;66(2):119-128. doi: 10.1007/s00011-016-0985-3. Epub 2016 Sep 21.
5
Role of the Wnt/β-catenin pathway in gastric cancer: An in-depth literature review.
World J Exp Med. 2015 May 20;5(2):84-102. doi: 10.5493/wjem.v5.i2.84.
6
Weight change therapy as a potential treatment for end-stage ovarian carcinoma.
Am J Case Rep. 2014 May 12;15:203-11. doi: 10.12659/AJCR.890229. eCollection 2014.
7
Role of viruses in the development of breast cancer.
Infect Agent Cancer. 2013 Sep 2;8:32. doi: 10.1186/1750-9378-8-32. eCollection 2013.

本文引用的文献

1
Epstein-Barr virus-associated gastric carcinoma: a newly defined entity.
J Clin Gastroenterol. 2012 Apr;46(4):262-71. doi: 10.1097/MCG.0b013e318249c4b8.
3
Fifteen-year effects of Helicobacter pylori, garlic, and vitamin treatments on gastric cancer incidence and mortality.
J Natl Cancer Inst. 2012 Mar 21;104(6):488-92. doi: 10.1093/jnci/djs003. Epub 2012 Jan 23.
4
The future for the treatment of genotype 4 chronic hepatitis C.
Liver Int. 2012 Feb;32 Suppl 1:146-50. doi: 10.1111/j.1478-3231.2011.02704.x.
6
Oncogenic potential of hepatitis C virus proteins.
Viruses. 2010 Sep;2(9):2108-2133. doi: 10.3390/v2092108. Epub 2010 Sep 27.
7
Helicobacter pylori Infection and Gastric Adenocarcinoma.
US Gastroenterol Hepatol Rev. 2011 Jun;7(1):59-64.
9
The role of oncogenic viruses in the pathogenesis of hepatocellular carcinoma.
Clin Liver Dis. 2011 May;15(2):261-79, vii-x. doi: 10.1016/j.cld.2011.03.001.
10
Gastric carcinogenesis.
Langenbecks Arch Surg. 2011 Aug;396(6):729-42. doi: 10.1007/s00423-011-0810-y. Epub 2011 May 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验